ARTICLE SYNOPSIS...Despite having suffered a sudden pullback in April 2012, shares of Fidelity Select Biotechnology have gone on to make new highs.
ARTICLE SYNOPSIS...Biotech stocks are pulling far ahead of the rest of the stock market in terms of relative strength.